291 filings
Page 5 of 15
DEFR14A
zhm0tj0qmn961
22 May 20
Revised proxy
6:01am
8-K
cuea9ydh
12 May 20
Regulation FD Disclosure
4:00pm
8-K
4fj8j
30 Apr 20
Genocea Provides First Quarter 2020 Corporate Update
7:04am
DEFA14A
6sm a0ite0
20 Apr 20
Additional proxy soliciting materials
4:07pm
S-8
lkek8rc blnbdenofc5
13 Feb 20
Registration of securities for employees
4:12pm
8-K
k7ynodd37ovvmwz7s6gh
13 Feb 20
Genocea Provides Fourth Quarter 2019 Corporate Update
7:03am
8-K
5u5 nr4n9ilt7q
13 Jan 20
Regulation FD Disclosure
9:48am
8-K
w0gy2m
19 Nov 19
Entry into a Material Definitive Agreement
4:04pm
424B5
ctocax1e
8 Nov 19
Prospectus supplement for primary offering
5:10pm
8-K
su1m tmunfnh
5 Nov 19
Confirm positive GEN-009 clinical immunogenicity results
8:06am
424B5
eiz zmpqiqiy
24 Oct 19
Prospectus supplement for primary offering
9:09am
8-K
4znbup 2ni2z2hcin
24 Oct 19
Entry into a Material Definitive Agreement
7:02am
8-K
dm9 g79da3m
25 Jul 19
Genocea Provides Corporate Update, Including Second-Quarter 2019 Financial Results
7:04am
424B4
zt109 pi49kl7r
21 Jun 19
Prospectus supplement with pricing info
4:01pm